Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.
about
Baicalein inhibits IL-1beta- and TNF-alpha-induced inflammatory cytokine production from human mast cells via regulation of the NF-kappaB pathwayGenomic amplification of a decoy receptor for Fas ligand in lung and colon cancerMetalloprotease-disintegrin MDC9: intracellular maturation and catalytic activityMolecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factorIsolation and sequence of the granulin precursor cDNA from human bone marrow reveals tandem cysteine-rich granulin domainsHuman lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localizationMolecular cloning of mouse tumour necrosis factor cDNA and its eukaryotic expressionOncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cellsImmunomodulation in stable renal transplant recipients with concomitant tacrolimus and sirolimus therapyCells, biomarkers, and post-traumatic stress disorder: evidence for peripheral involvement in a central diseaseHistorical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journeyNutrition, insulin resistance and dysfunctional adipose tissue determine the different components of metabolic syndromeIdentification of a receptor for BLyS demonstrates a crucial role in humoral immunityIdentification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinaseCatalytic properties of ADAM19Lasker Clinical Medical Research Award. TNF defined as a therapeutic target for rheumatoid arthritis and other autoimmune diseasesIdentification and characterization of a pro-tumor necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteasesAnticancer and immunosuppressive properties of bacterial prodigininesERK signaling mediates the induction of inflammatory cytokines by bufalin in human monocytic cellsCytokines and particle-induced inflammatory cell recruitmentA multi-targeted approach to suppress tumor-promoting inflammationCloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factorMolecular cloning and expression of the type 1 and type 2 murine receptors for tumor necrosis factorAssessment of Anti-TNF-α Activities in Keratinocytes Expressing Inducible TNF- α: A Novel Tool for Anti-TNF-α Drug ScreeningRegulation of the mRNA for monocyte-derived neutrophil-activating peptide in differentiating HL60 promyelocytesIncreased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistanceInterleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytesIdentification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediatorsTNF superfamily: a growing saga of kidney injury modulators.Evaluation of serum levels of tumour necrosis factor-alpha (TNF-alpha) and soluble IL-2 receptor (sIL-2R) and CD4, CD8 and natural killer (NK) populations during infrared pulsed laser device (IPLD) treatment.Molecular cloning, expression and characterization of ovine TNF alpha.Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific.Identification of novel single nucleotide polymorphisms in inflammatory genes as risk factors associated with trachomatous trichiasis.Tumor necrosis factor induces glomerular damage in the rabbit.The SWISS-PROT protein sequence data bank, recent developments.Targeting TNF and TNF Receptor Pathway in HIV-1 Infection: from Immune Activation to Viral ReservoirsAmplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor alpha in NIH 3T3 cellsCharacterization of a tumor necrosis factor alpha (TNF-alpha) inhibitor: evidence of immunological cross-reactivity with the TNF receptor.Association of combined maternal-fetal TNF-alpha gene G308A genotypes with preterm delivery: a gene-gene interaction study.The rationale for the current boom in anti-TNFalpha treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFalpha and minimise hazards?
P2860
Q21245666-4E69FE65-6C52-4F52-B68D-9110BE892C82Q22008593-6E445F6D-862A-4799-8FDB-E804A453A40AQ22008720-7FA9DCCD-D087-44DF-B1A9-9C63A6E6FF14Q24300194-1D55D90E-582A-47FE-B2D4-239C0837D9CEQ24305310-24DC9E71-7B1E-4D5E-A113-42DB7757DE94Q24625033-90979A92-16DA-45D9-B285-CEA6D1A00404Q24626916-B45208A6-9D7F-46EE-B058-B4CD8C7CDD80Q24627585-CB66CFBE-195D-4F2B-9DC8-9CFBB9738C14Q24799790-A4CC66A4-1E3D-4F71-A795-BDB8656A7C7EQ26830476-34F88848-08DF-47FC-8E2C-C48D9023BCAAQ26991848-5B62C1B2-19CD-44FB-9D7D-FA9D10F9883CQ28079661-A0802B2F-0281-4FC3-886F-E8112F2EAFF8Q28139967-2FB42B08-757A-449A-838B-C19183D47D11Q28144774-715980BA-8F55-492D-B28A-B8303FFE9BE0Q28189426-E06C3AF1-8FF7-4D9F-A269-44D358AA5BFEQ28206018-EFDB1E07-75EB-44F4-B098-42767AFF31FBQ28249632-EE063700-158C-46FD-9115-6480424D5BD5Q28258853-64D9796E-E217-4208-AAA1-40EBDBDC3285Q28372933-62797B59-149F-4D81-B475-477D18A84665Q28388924-4A5548E3-5672-47FE-B1D2-EEAD714DEFD7Q28393278-778E2622-3220-4AA1-A5E5-52B6C56D70AAQ28507398-7EA46F58-589F-4724-BCC9-763E9E295B46Q28512161-19F33881-D729-4993-8146-66F54A1585B7Q28552630-7D58BAC8-3429-44AE-B78C-1ACF3E0A367BQ28609877-7EDE3F31-6EAF-4E32-B73F-40F769F997FDQ29012156-597EB6C8-B5D9-4916-A206-6D1BBA2F6850Q29619621-B8409355-F3E6-4A66-92C7-FD62EB00909EQ29619837-47967DD4-CF09-4C00-ADFD-56A94C14EB17Q30479123-AAA74BE1-578D-4A7C-B9D5-A2547B6F402AQ30737786-D3EE95FC-15AC-4267-B99D-39CFC408DF9BQ30834362-0BCB4C4A-8BB6-426A-8DDB-E89CE5A56361Q33336314-56B18CB3-3407-461A-BF3A-35B6654B1DDEQ33381603-549063D2-C166-4C1C-B9DE-1F1BA5065005Q33444321-FFB47DBF-36DB-476A-B322-577A7C340FB8Q33463515-B0CF6EEF-5D00-495C-AEFB-4E2E3A9F3DF8Q33613493-1C744DD5-1309-4ECE-946D-F3911661CB30Q33632011-3B45E2EF-1334-46EB-ACE2-5771C9FEDF69Q33673534-B129E6C9-E296-4D5F-B610-99C09251FA8BQ33718019-E289A555-4E7C-4FCF-AD47-5B2F75F70C56Q33782321-837ED54D-91CB-43C9-BA92-F036919880F7
P2860
Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin.
description
1984 nî lūn-bûn
@nan
1984 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Human tumour necrosis factor: ...... n and homology to lymphotoxin.
@ast
Human tumour necrosis factor: ...... n and homology to lymphotoxin.
@en
Human tumour necrosis factor: ...... n and homology to lymphotoxin.
@nl
type
label
Human tumour necrosis factor: ...... n and homology to lymphotoxin.
@ast
Human tumour necrosis factor: ...... n and homology to lymphotoxin.
@en
Human tumour necrosis factor: ...... n and homology to lymphotoxin.
@nl
prefLabel
Human tumour necrosis factor: ...... n and homology to lymphotoxin.
@ast
Human tumour necrosis factor: ...... n and homology to lymphotoxin.
@en
Human tumour necrosis factor: ...... n and homology to lymphotoxin.
@nl
P2093
P356
P1433
P1476
Human tumour necrosis factor: ...... n and homology to lymphotoxin.
@en
P2093
Aggarwal BB
Goeddel DV
Hayflick JS
Palladino MA
Seeburg PH
P2888
P304
P356
10.1038/312724A0
P407
P577
1984-12-01T00:00:00Z
P6179
1046917469